Iatrogenic haemolysis from primaquine is dose dependent; in red 1mg/kg/day (7-day short course high dose) and in orange 0.5mg/kg/day (standard high dose). G6PD heterozygotes who have normal G6PD activity (>30%) develop large fractional haematocrit reductions. Circled individuals received a blood transfusion.
